LOX and head and neck cancer: They produce abundant fibrillar collagen and promote lysyl oxidase (LOX)‐mediated collagen crosslinking, increasing matrix stiffness and impairing drug delivery, particularly in myofibroblastic CAF subsets such as those in head and neck cancers, where NOX4/ROS‐dependent activation is involved.